These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Updated guidelines for occupational postexposure prophylaxis. del Rio C AIDS Clin Care; 2005 Dec; 17(12):114. PubMed ID: 16388540 [No Abstract] [Full Text] [Related]
33. Simplifying suppression: switching therapies to improve HIV disease management. Moyle GJ AIDS Read; 2004 Jul; 14(7):380-4. PubMed ID: 15282867 [No Abstract] [Full Text] [Related]
34. New pediatric dosing recommendations for atazanavir. AIDS Patient Care STDS; 2008 Apr; 22(4):347. PubMed ID: 18434948 [No Abstract] [Full Text] [Related]
35. Report from ICAAC: new drugs and antiretroviral therapy for naïve patients. Gallant JE Hopkins HIV Rep; 2002 Nov; 14(6):1-3, 7. PubMed ID: 12491989 [No Abstract] [Full Text] [Related]
36. Editorial comment: tenofovir-related nephrotoxicity--who's at risk? Gupta Samir K AIDS Read; 2007 Feb; 17(2):102-3. PubMed ID: 17323509 [No Abstract] [Full Text] [Related]
37. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Introduction. TreatmentUpdate; 2003; 15(3):1. PubMed ID: 17216843 [No Abstract] [Full Text] [Related]
38. Protease inhibitor boosting is complex, requires thorough knowledge of interactions. Monier P HIV Clin; 2004; 16(3):1-3. PubMed ID: 15366104 [No Abstract] [Full Text] [Related]
39. Report from the 12th Retrovirus Conference. Adherence. Friedland GH; Nagy GS AIDS Clin Care; 2005 Apr; 17(4):36. PubMed ID: 15875309 [No Abstract] [Full Text] [Related]
40. Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. ALTAIR--the end of NRTI-only regimes. Albrecht H J Watch AIDS Clin Care; 2009 Oct; 21(10):82. PubMed ID: 20458813 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]